Scope
Reference
CU.1863.HM
Description
T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes). The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan. Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia. Funding was agreed in Dec 2023.
An endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring device. These devices are marketed by different companies with different specifications.
Contract 1. T1D-Plus study with Dexcom
Supplier
Contract value
- £76,000 excluding VAT
- £91,200 including VAT
Below the relevant threshold
Award decision date
19 January 2026
Earliest date the contract will be signed
19 January 2026
Contract dates (estimated)
- 20 January 2026 to 20 January 2027
- 1 year, 1 day
Main procurement category
Goods
CPV classifications
- 30210000 - Data-processing machines (hardware)
Contract locations
- UK - United Kingdom
Procedure
Procedure type
Below threshold - without competition
Supplier
91,200
1 Tanfield
Edinburgh
EH3 5DA
United Kingdom
Email: sian.rilstone@dexcom.com
Region: UKM75 - Edinburgh, City of
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Contract 1. T1D-Plus study with Dexcom
Contracting authority
CARDIFF UNIVERSITY
- Companies House: RC000089
- Public Procurement Organisation Number: PHVT-4343-HWYR
Park Place
Cardiff
CF10 3AT
United Kingdom
Email: procurement@cardiff.ac.uk
Website: http://www.cardiff.ac.uk
Region: UKL22 - Cardiff and Vale of Glamorgan
Organisation type: Public authority - sub-central government
Devolved regulations that apply: Wales